Espinola ZN, Lupi HE

Idioma: Español
Referencias bibliográficas: 29
Paginas: 199-205
Archivo PDF: 408.33 Kb.

RESUMEN

El presente estudio es una revisión de la utilidad del ecocardiograma en la detección subclínica de la disfunción sistólica ventricular izquierda de los pacientes sometidos a quimioterapia, antes de que el daño miocárdico sea irreversible. Se abordan los parámetros clásicos en la evaluación sistolo-diastólica ventricular así como los más actuales, resaltando el papel de las nuevas técnicas ecocardiográficas como son el ecocardiograma tridimensional en la evaluación de la fracción de expulsión del ventrículo izquierdo y la técnica de speckle tracking en la valoración de la deformación de la fibra miocárdica ventricular.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Geiger S, Lange V, Suhl P, Heinemann V, Stemmler HJ. Anticancer therapy induced cardiotoxicity: review of the literature. Anticancer Drugs. 2010; 21: 578-590.

2. Plana JC, Galderisi M, Barac A, Ewer MS, Ky B, Scherrer-Crosbie M et al. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: A report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2014; 27: 911-939.

3. Lal H, Kolaja KL, Force T. Cancer genetics and the cardiotoxicity of the therapeutics. J Am Coll Cardiol. 2013; 61: 267-274.

4. Zhang S, Liu X, Bawa-Khalfe T, Lu LS, Liu LF, Yeh ET. Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med. 2012; 18: 1639-1642.

5. Friedman MA, Bozdech MJ, Billingham ME, Rider AK. Doxorubicin cardiotoxicity. Serial endomyocardial biopsies and systolic time intervals. JAMA. 1978; 240: 1603-1606.

6. Ewer MS, Lippman SM. Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity. J Clin Oncol. 2005; 23: 2900-2902.

7. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015; 28: 1-39.

8. Gottdiener JS, Mathisen DJ, Borer JS, Bonow RO, Myers CE, Barr LH et al. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med. 1981; 94: 430-435.

9. Epstein FH. MRI of left ventricular function. J Nucl Cardiol. 2007; 14: 729-744.

10. Plana JC. La quimioterapia y el corazón. Rev Esp Cardiol. 2011; 64: 409-415.

11. Salgado AA, Dias Coelho Filho C, de Souza Segrégio Reis C. El papel del ecocardiograma en la quimioterapia. Arq Bras Cardiol. 2014; 27: 18-23.

12. Badano LP, Boccalini F, Muraru D, Bianco LD, Peluso D, Bellu R et al. Current clinical applications of transthoracic three-dimensional echocardiography. J Cardiovasc Ultrasound. 2012; 20: 1-22.

13. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM et al. American Society of Echocardio­graphy Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr. 2008; 21: 1179-1201.

14. Muraru D, Badano LP, Peluso D, Dal Bianco L, Casablanca S, Kocabay G et al. Comprehensive analysis of left ventricular geo­metry and function by three-dimensional echocardiography in healthy adults. J Am Soc Echocardiogr. 2013; 26: 618-628.

15. Poterucha JT, Kutty S, Lindquist RK, Li L, Eidem BW. Chan­ges in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr. 2012; 25: 733-740.

16. Jassal DS, Han SY, Hans C, Sharma A, Fang T, Ahmadie R. Utility of tissue Doppler and strain rate imaging in the early detection of trastuzumab and anthracycline mediated cardiomyopathy. J Am Soc Echocardiogr. 2009; 22: 418-424.

17. Daher IN, Kim C, Saleh RR, Plana JC, Yusuf SW, Banchs J. Prevalence of abnormal echocardiographic findings in cancer patients: a retrospective evaluation of echocardiography for identifying cardiac abnormalities in cancer patients. Echocardiography. 2011; 28: 1061-1067.

18. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000; 342: 1077-1084.

19. Kuznetsova T, Herbots L, Lopez B, Jin Y, Richart T, Thijs L et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009; 2: 105-112.

20. Dorup I, Levitt G, Sullivan I, Sorensen K. Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function. Heart. 2004; 90: 1214-1216.

21. Eidem BW, Sapp BG, Suarez CR, Cetta F. Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children. Am J Cardiol. 2001; 87: 1120-1122.

22. Ishii M, Tsutsumi T, Himeno W, Eto G, Furui J, Hashino K et al. Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy. Am J Cardiol. 2000; 86: 1279-1281.

23. Rietzschel ER, De Buyzere ML, Bekaert S, Segers P, De Bacquer D, Cooman L et al. Rationale, design, methods and baseline characteristics of the Asklepios Study. Eur J Cardiovasc Prev Rehabil. 2007; 14: 179-191.

24. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr et al. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988; 41: 1105-1116.

25. Lancellotti P, Badano LP, Lang RM, Akhaladze N, Athanassopoulos GD, Barone D et al. Normal reference ranges for echocardiography: rationale, study design, and methodology (NORRE Study). Eur Heart J Cardiovasc Imaging. 2013; 14: 303-308.

26. Senior R, Becher H, Monaghan M, Agati L, Zamorano J, Vanoverschelde JL et al. Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography. Eur J Echocardiogr. 2009; 10: 194-212.

27. Dandel M, Lehmkuhl H, Knosalla C, Suramelashvili N, Hetzer R. Strain and strain rate imaging by echocardiography-basic concepts and clinical applicability. Curr Cardiol Rev. 2009; 5: 133-148.

28. Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol. 2014; 63: 2751-2768.

29. Jurcut R, Wildiers H, Ganame J, D’hooge J, De Backer J, Denys H et al. Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer. J Am Soc Echocardiogr. 2008; 21: 1283-1289.